This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Madecassoside
- DrugBank Accession Number
- DB15532
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Madecassoside (DB15532)
- Weight
- Average: 975.132
Monoisotopic: 974.508644912 - Chemical Formula
- C48H78O20
- Synonyms
- Asiaticoside A
- Redermic
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image CareMe Madecassoside Cica Derma Repair Control Treatment Cream 0.1 g/100mL Topical MIRINAGLOBAL 2020-03-21 Not applicable US 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Dr.Different CICA Metal Madecassoside (0.26 g/100g) + Asiaticoside (0.012 g/100g) Cream Topical Dareun Cosmetics Co., Ltd. 2021-05-01 Not applicable US Dr.Different CICA Metal Calming Pad Madecassoside (0.009 g/90mL) + Centella asiatica (0.045 g/90mL) Liquid Topical Dareun Cosmetics Co., Ltd. 2021-09-01 Not applicable US Karatica Im Cica Essence Pack Madecassoside (0.01 g/100mL) + Asiatic acid (0.01 g/100mL) + Asiaticoside (0.01 g/100mL) + Madecassic acid (0.01 g/100mL) Liquid Topical Karatica Co., Ltd 2019-08-17 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image CareMe Madecassoside Cica Derma Repair Control Treatment Madecassoside (0.1 g/100mL) Cream Topical MIRINAGLOBAL 2020-03-21 Not applicable US Dr.Different CICA Metal Madecassoside (0.26 g/100g) + Asiaticoside (0.012 g/100g) Cream Topical Dareun Cosmetics Co., Ltd. 2021-05-01 Not applicable US Dr.Different CICA Metal Calming Pad Madecassoside (0.009 g/90mL) + Centella asiatica (0.045 g/90mL) Liquid Topical Dareun Cosmetics Co., Ltd. 2021-09-01 Not applicable US Karatica Im Cica Essence Pack Madecassoside (0.01 g/100mL) + Asiatic acid (0.01 g/100mL) + Asiaticoside (0.01 g/100mL) + Madecassic acid (0.01 g/100mL) Liquid Topical Karatica Co., Ltd 2019-08-17 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as triterpene saponins. These are glycosylated derivatives of triterpene sapogenins. The sapogenin moiety backbone is usually based on the oleanane, ursane, taraxastane, bauerane, lanostane, lupeol, lupane, dammarane, cycloartane, friedelane, hopane, 9b,19-cyclo-lanostane, cycloartane, or cycloartanol skeleton.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- Sub Class
- Terpene glycosides
- Direct Parent
- Triterpene saponins
- Alternative Parents
- Triterpenoids / Oligosaccharides / 12-beta-hydroxysteroids / 7-alpha-hydroxysteroids / O-glycosyl compounds / Oxanes / Secondary alcohols / Cyclic alcohols and derivatives / Carboxylic acid esters / Polyols show 7 more
- Substituents
- 12-beta-hydroxysteroid / 12-hydroxysteroid / 7-alpha-hydroxysteroid / 7-hydroxysteroid / Acetal / Alcohol / Aliphatic heteropolycyclic compound / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester show 19 more
- Molecular Framework
- Aliphatic heteropolycyclic compounds
- External Descriptors
- carboxylic ester, trisaccharide derivative, triterpenoid saponin, pentacyclic triterpenoid (CHEBI:66651)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- CQ2F5O6YIY
- CAS number
- 34540-22-2
- InChI Key
- BNMGUJRJUUDLHW-HCZMHFOYSA-N
- InChI
- InChI=1S/C48H78O20/c1-19-10-11-48(13-12-46(6)22(28(48)20(19)2)8-9-27-44(4)14-24(52)39(61)45(5,18-50)38(44)23(51)15-47(27,46)7)43(62)68-42-35(59)32(56)30(54)26(66-42)17-63-40-36(60)33(57)37(25(16-49)65-40)67-41-34(58)31(55)29(53)21(3)64-41/h8,19-21,23-42,49-61H,9-18H2,1-7H3/t19-,20+,21+,23-,24-,25-,26-,27-,28+,29+,30-,31-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42+,44-,45+,46-,47-,48+/m1/s1
- IUPAC Name
- (2S,3R,4S,5S,6R)-6-({[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl (1S,2R,4aS,6aS,6bR,8R,8aR,9R,10R,11R,12aR,12bR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
- SMILES
- [H][C@@]1(O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CC[C@@H](C)[C@H](C)[C@@]4([H])C4=CC[C@]6([H])[C@@]7(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@]7([H])[C@H](O)C[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
References
- General References
- Not Available
- External Links
- ChemSpider
- 28639016
- BindingDB
- 23212
- 87855
- ChEBI
- 66651
- ZINC
- ZINC000253529433
- Wikipedia
- Centella_asiatica
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical 0.1 g/100mL Cream Topical Liquid Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1.71 mg/mL ALOGPS logP -0.03 ALOGPS logP -1.8 Chemaxon logS -2.8 ALOGPS pKa (Strongest Acidic) 11.75 Chemaxon pKa (Strongest Basic) -3.6 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 19 Chemaxon Hydrogen Donor Count 13 Chemaxon Polar Surface Area 335.44 Å2 Chemaxon Rotatable Bond Count 10 Chemaxon Refractivity 234.14 m3·mol-1 Chemaxon Polarizability 103.17 Å3 Chemaxon Number of Rings 8 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 308.5596663 predictedDarkChem Lite v0.1.0
Drug created at October 09, 2019 21:52 / Updated at June 12, 2020 16:53